nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—ESR1—urinary bladder cancer	0.891	1	CbGaD
Allylestrenol—CYP3A4—urine—urinary bladder cancer	0.00277	0.134	CbGeAlD
Allylestrenol—PGR—prostate gland—urinary bladder cancer	0.00228	0.11	CbGeAlD
Allylestrenol—Quinestrol—ESR1—urinary bladder cancer	0.00179	0.27	CrCbGaD
Allylestrenol—ESR1—prostate gland—urinary bladder cancer	0.00178	0.0863	CbGeAlD
Allylestrenol—PGR—epithelium—urinary bladder cancer	0.00167	0.0811	CbGeAlD
Allylestrenol—PGR—smooth muscle tissue—urinary bladder cancer	0.00161	0.0782	CbGeAlD
Allylestrenol—Ethynodiol—ESR1—urinary bladder cancer	0.00148	0.223	CrCbGaD
Allylestrenol—Desogestrel—ESR1—urinary bladder cancer	0.00134	0.202	CrCbGaD
Allylestrenol—ESR1—epithelium—urinary bladder cancer	0.00131	0.0634	CbGeAlD
Allylestrenol—ESR1—smooth muscle tissue—urinary bladder cancer	0.00126	0.0611	CbGeAlD
Allylestrenol—Norgestimate—ESR1—urinary bladder cancer	0.00126	0.189	CrCbGaD
Allylestrenol—PGR—female reproductive system—urinary bladder cancer	0.00124	0.0603	CbGeAlD
Allylestrenol—ESR1—renal system—urinary bladder cancer	0.00122	0.0588	CbGeAlD
Allylestrenol—PGR—vagina—urinary bladder cancer	0.00113	0.0545	CbGeAlD
Allylestrenol—ESR1—female reproductive system—urinary bladder cancer	0.000973	0.0471	CbGeAlD
Allylestrenol—ESR1—vagina—urinary bladder cancer	0.00088	0.0426	CbGeAlD
Allylestrenol—Levonorgestrel—ESR1—urinary bladder cancer	0.000769	0.116	CrCbGaD
Allylestrenol—PGR—lymph node—urinary bladder cancer	0.000728	0.0352	CbGeAlD
Allylestrenol—CYP3A4—renal system—urinary bladder cancer	0.000678	0.0328	CbGeAlD
Allylestrenol—ESR1—lymph node—urinary bladder cancer	0.000569	0.0276	CbGeAlD
Allylestrenol—CYP3A4—female reproductive system—urinary bladder cancer	0.000543	0.0263	CbGeAlD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000439	0.00538	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—urinary bladder cancer	0.000427	0.00523	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—CREBBP—urinary bladder cancer	0.000424	0.00519	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—RB1—urinary bladder cancer	0.000422	0.00517	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—S100B—urinary bladder cancer	0.000417	0.00511	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000408	0.005	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—urinary bladder cancer	0.000402	0.00492	CbGpPWpGaD
Allylestrenol—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000395	0.00484	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000393	0.00481	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.000391	0.0048	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—RHOA—urinary bladder cancer	0.000391	0.00479	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000389	0.00476	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000381	0.00467	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000378	0.00463	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000375	0.00459	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000372	0.00456	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—CDKN2A—urinary bladder cancer	0.000371	0.00455	CbGpPWpGaD
Allylestrenol—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000371	0.00454	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.00037	0.00453	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—TERT—urinary bladder cancer	0.000369	0.00452	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000364	0.00446	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000351	0.0043	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000341	0.00418	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—RBX1—urinary bladder cancer	0.000338	0.00414	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—ATM—urinary bladder cancer	0.000332	0.00406	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000323	0.00395	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.000322	0.00394	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000319	0.00391	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—CCND1—urinary bladder cancer	0.000314	0.00384	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—urinary bladder cancer	0.00031	0.0038	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000306	0.00375	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000303	0.00371	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000297	0.00363	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000295	0.00361	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—ESR1—urinary bladder cancer	0.000294	0.00361	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—EP300—urinary bladder cancer	0.000289	0.00354	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000287	0.00352	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—SRC—urinary bladder cancer	0.000286	0.00351	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000282	0.00346	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000278	0.00341	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000268	0.00329	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000261	0.0032	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.000256	0.00314	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000253	0.0031	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.000252	0.00308	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000251	0.00307	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00025	0.00306	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000247	0.00302	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000247	0.00302	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.000245	0.003	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000241	0.00295	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00024	0.00294	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00024	0.00294	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000239	0.00293	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.000239	0.00293	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000237	0.00291	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000237	0.0029	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000237	0.0029	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000234	0.00286	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000229	0.0028	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000224	0.00274	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000224	0.00274	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000223	0.00273	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.00022	0.00269	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.00022	0.00269	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.00022	0.00269	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000219	0.00268	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000218	0.00267	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000217	0.00265	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.000216	0.00265	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000216	0.00265	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000214	0.00262	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000213	0.00261	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000208	0.00255	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000206	0.00252	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.000203	0.00248	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000202	0.00248	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000201	0.00247	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000201	0.00246	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000201	0.00246	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000198	0.00242	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000197	0.00242	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000195	0.00239	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000192	0.00235	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000189	0.00231	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000185	0.00227	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CDKN1A—urinary bladder cancer	0.000185	0.00226	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—PTEN—urinary bladder cancer	0.000184	0.00226	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000184	0.00225	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.00018	0.0022	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000179	0.0022	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000178	0.00218	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000177	0.00216	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000175	0.00215	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000174	0.00214	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.000171	0.0021	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000171	0.00209	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00017	0.00209	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000167	0.00205	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000167	0.00205	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000164	0.00201	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000155	0.0019	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000152	0.00186	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000151	0.00185	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—EGFR—urinary bladder cancer	0.00015	0.00184	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000149	0.00182	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000145	0.00178	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000145	0.00177	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—KRAS—urinary bladder cancer	0.000142	0.00173	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000137	0.00168	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000132	0.00161	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00013	0.00159	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HDAC4—urinary bladder cancer	0.00013	0.00159	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.000127	0.00155	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000126	0.00155	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000125	0.00153	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	0.000124	0.00152	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000122	0.00149	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—HRAS—urinary bladder cancer	0.00012	0.00147	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000118	0.00144	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000113	0.00138	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000111	0.00136	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SMC1A—urinary bladder cancer	0.000111	0.00136	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000109	0.00133	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GLI1—urinary bladder cancer	0.000109	0.00133	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	0.000108	0.00133	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	0.000108	0.00132	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000107	0.00131	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000106	0.00129	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000105	0.00129	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000104	0.00127	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000103	0.00127	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000102	0.00125	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ESR2—urinary bladder cancer	9.67e-05	0.00118	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	9.34e-05	0.00114	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	9.1e-05	0.00112	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	9.04e-05	0.00111	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	9.03e-05	0.00111	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	9.01e-05	0.0011	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	8.84e-05	0.00108	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	8.79e-05	0.00108	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.59e-05	0.00105	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	8.36e-05	0.00102	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	8.35e-05	0.00102	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	8.31e-05	0.00102	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	7.61e-05	0.000933	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.49e-05	0.000917	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—NCOR1—urinary bladder cancer	7.47e-05	0.000915	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RBX1—urinary bladder cancer	7.45e-05	0.000913	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	7.42e-05	0.000909	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	7.32e-05	0.000897	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.07e-05	0.000866	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	7.06e-05	0.000865	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ERCC2—urinary bladder cancer	7.02e-05	0.00086	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TSC1—urinary bladder cancer	7.01e-05	0.000858	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.97e-05	0.000854	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.97e-05	0.000854	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.92e-05	0.000848	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—JAG1—urinary bladder cancer	6.67e-05	0.000817	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	6.52e-05	0.000799	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SMC1A—urinary bladder cancer	6.51e-05	0.000798	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.5e-05	0.000796	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.41e-05	0.000785	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	6.38e-05	0.000782	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—MYC—urinary bladder cancer	6.34e-05	0.000776	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	6.27e-05	0.000768	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.15e-05	0.000753	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ESR1—urinary bladder cancer	5.87e-05	0.000719	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ESR2—urinary bladder cancer	5.68e-05	0.000695	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—S100B—urinary bladder cancer	5.4e-05	0.000661	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPARG—urinary bladder cancer	5.35e-05	0.000656	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CREBBP—urinary bladder cancer	5.14e-05	0.00063	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NCOR1—urinary bladder cancer	4.86e-05	0.000595	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NCOR1—urinary bladder cancer	4.38e-05	0.000537	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	4.37e-05	0.000536	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.33e-05	0.00053	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TERT—urinary bladder cancer	4.28e-05	0.000524	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ERCC2—urinary bladder cancer	4.12e-05	0.000505	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	4.11e-05	0.000504	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.11e-05	0.000503	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.11e-05	0.000503	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGFR3—urinary bladder cancer	3.93e-05	0.000481	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	3.91e-05	0.000479	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ESR1—urinary bladder cancer	3.81e-05	0.000467	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.75e-05	0.00046	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.72e-05	0.000456	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.38e-05	0.000414	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CREBBP—urinary bladder cancer	3.34e-05	0.000409	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1—urinary bladder cancer	3.3e-05	0.000404	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.19e-05	0.000391	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—S100B—urinary bladder cancer	3.17e-05	0.000388	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARG—urinary bladder cancer	3.14e-05	0.000385	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.11e-05	0.000381	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—MYC—urinary bladder cancer	3.05e-05	0.000374	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RHOA—urinary bladder cancer	3.02e-05	0.00037	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CREBBP—urinary bladder cancer	3.02e-05	0.00037	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.85e-05	0.000349	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ERBB2—urinary bladder cancer	2.8e-05	0.000343	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL8—urinary bladder cancer	2.65e-05	0.000325	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL2—urinary bladder cancer	2.54e-05	0.000311	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TERT—urinary bladder cancer	2.51e-05	0.000308	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.49e-05	0.000305	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCND1—urinary bladder cancer	2.47e-05	0.000303	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—urinary bladder cancer	2.4e-05	0.000294	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN1A—urinary bladder cancer	2.39e-05	0.000293	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTEN—urinary bladder cancer	2.39e-05	0.000292	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.3e-05	0.000282	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EP300—urinary bladder cancer	2.28e-05	0.000279	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.25e-05	0.000276	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SRC—urinary bladder cancer	2.21e-05	0.000271	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MYC—urinary bladder cancer	1.98e-05	0.000243	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.96e-05	0.00024	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.94e-05	0.000238	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EGFR—urinary bladder cancer	1.94e-05	0.000238	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.94e-05	0.000237	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—KRAS—urinary bladder cancer	1.83e-05	0.000225	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.8e-05	0.00022	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.8e-05	0.00022	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—MYC—urinary bladder cancer	1.79e-05	0.000219	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.77e-05	0.000217	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.74e-05	0.000214	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.64e-05	0.000201	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TP53—urinary bladder cancer	1.63e-05	0.0002	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.56e-05	0.000191	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HRAS—urinary bladder cancer	1.56e-05	0.000191	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.49e-05	0.000182	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.45e-05	0.000178	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.45e-05	0.000178	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.41e-05	0.000173	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.4e-05	0.000172	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.4e-05	0.000172	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.34e-05	0.000164	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.3e-05	0.000159	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	0.000148	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.16e-05	0.000143	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.14e-05	0.00014	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.12e-05	0.000138	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	0.000136	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	0.000136	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.08e-05	0.000132	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.06e-05	0.00013	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.04e-05	0.000128	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.82e-06	0.00012	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TP53—urinary bladder cancer	9.56e-06	0.000117	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	9.14e-06	0.000112	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.96e-06	9.75e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.65e-06	9.37e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.26e-06	7.67e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.46e-06	6.69e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.21e-06	6.38e-05	CbGpPWpGaD
